After 6 months, the tirzepatide group’s weight loss averaged 10.1%, compared to 5.8% for semaglutide. After 1 year, average body weight loss was 15.3% with tirzepatide, and 8.3% with semaglutide.

A new study compared the effectiveness of weight-loss drugs tirzepatide and semaglutide, finding tirzepatide leads to greater weight loss and waist reduction. Doctors shared insights.

This article highlights the first head-to-head study comparing two popular injectable weight-loss medications, semaglutide (Wegovy) and tirzepatide (Zepbound). Conducted by Weill Cornell Medicine ...

In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic ...

Mounjaro was first approved in May of 2022 for diabetes and is part of the same class of drugs, glucagon-like peptide-1 (GLP-1) agonists, as another FDA-approved weight loss drug called ...